Arki Pharmaceuticals Llp - Company Profile

It is a pharma limited liability partnership based in Pune, Maharashtra, India, established in 2017.
2017 Pune, Maharashtra, India Active
Last Updated:
Access Report
About Arki Pharmaceuticals Llp

Arki Pharmaceuticals Llp, a active limited liability partnership, was established on 23 March 2017 in Pune, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAI-9154. Registered under ROC Roc Pune. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Nanasaheb Prabhakarrao Dhavan (Designated Partner), Subhash Sopanrao Suryawanshi (Designated Partner). Past directors included Chirag Bipinchandra Shah. Its latest date of accounts and solvency statement 31 March 2024. It is based at Flat No.302, Wing A-3, S.No.6/2 To 6/5, Oxyzen Valley Narhegaon,, Pune, Maharashtra, 411041.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAI-9154

  • Incorporation Date

    23 March 2017

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Pune

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 8 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
Company report

Arki Pharmaceuticals Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Arki Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Arki Pharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Nanasaheb Prabhakarrao Dhavan Designated Partner 03 Jan 2019 Current
Subhash Sopanrao Suryawanshi Designated Partner 23 Mar 2017 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner 03 Jan 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Arki Pharmaceuticals Llp.

Enhance accessibility to Arki Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Arki Pharmaceuticals Llp revenue growth over time
Arki Pharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Arki Pharmaceuticals Llp?

Unlock access to Arki Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Arki Pharmaceuticals Llp?

Unlock and access historical data on people associated with Arki Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Arki Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arki Pharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Arki Pharmaceuticals Llp
Recent Activity within the Organization
  • Annual General Meeting

    Arki Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2024 as per latest MCA records. was recorded as a recent event.

  • Statement of Assets & Liabilities

    Arki Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was recorded as a recent event.

  • Director Appointment

    Nanasaheb Prabhakarrao Dhavan was appointed as a Designated Partner was appointed as a Designated Partner on 03 Jan 2019 & has been associated with this company since 7 years 1 month . was recorded as a recent event.

  • Director Appointment

    Subhash Sopanrao Suryawanshi was appointed as a Designated Partner was appointed as a Designated Partner on 23 Mar 2017 & has been associated with this company since 8 years 11 months . was recorded as a recent event.

  • LLP Incorporation

    Progress on Arki Pharmaceuticals Llp was registered on 23 Mar 2017 with Roc Pune & aged 8 years 11 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Arki Pharmaceuticals Llp?

The LLPIN of Arki Pharmaceuticals Llp is AAI-9154.

Where is Arki Pharmaceuticals Llp headquartered?

Arki Pharmaceuticals Llp is headquartered at Flat No.302, Wing A-3, S.No.6/2 To 6/5, Oxyzen Valley Narhegaon,, Pune, Maharashtra, 411041.

When was Arki Pharmaceuticals Llp incorporated?

Arki Pharmaceuticals Llp was incorporated on 23 March 2017.

Who are the current directors of Arki Pharmaceuticals Llp?

The current directors of Arki Pharmaceuticals Llp are

What is the primary industry of Arki Pharmaceuticals Llp?

The primary industry of Arki Pharmaceuticals Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available